Don't know the history/calibration of trials run in India. I see that even big players like AZN were running some schizophrenia trials (sites) there. Yes, psychosis tends to be judged relatively subjectively and differ between countries but I think the PANSS score, which includes 30 items such as delusions, hallucinatory behavior, and anxiety, is quite universal and well established. The question I had in mind is whether Indian patients tend to comply better than American ones to the treatment as they may view trial participation as a way to get improved care.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.